Skip to main content

Novavax faces high stakes FDA review this week that will decide the fate of its Covid vaccine in the U.S.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.